| Cancer news and resources for health care professionals |  |
| Patient-Centered Cancer Care
|  |  |
|
- Few cancer patients are advised on fatigue treatments
Researchers surveyed 160 cancer patients who experienced moderate to severe fatigue and found that just 10% of them were advised to be more physically active or to try other nondrug measures of reducing fatigue. Cancer types played a major role in whether or not patients get fatigue treatments, the study in the journal Supportive Care in Cancer found. HealthDay News
(12/27)
    
- Fertility drugs don't raise risk of uterine cancer recurrence
Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a study in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments. PhysiciansBriefing.com/HealthDay News
(12/26)
- Cancer-related deaths higher among psychiatric patients
Individuals with psychiatric disorders were 30% more likely to die from cancer than were people in the general population, an Australian study in the Archives of General Psychiatry found. Psychiatric patients weren't at greater risk for developing cancer, but it was frequently diagnosed later. HealthDay News
(12/19)
| Emerging Trends, Products & Technologies
| | |
|
- Study: CRC screening is no better with online education
A study of more than 900 women found online educational materials aimed at improving colorectal cancer screening rates were no more effective than printed outreach materials or usual care, according to researchers from Fox Chase Cancer Center and Case Western. Only about 12% of women were screened regardless of educational materials, which gastroenterologist Dr. Hemant Roy said was "flabbergastingly disappointing." WBUR-FM (Boston)/National Public Radio
(12/21)
| Cancer Research & Health Policy
| | |
|
- Drug shortages threaten cancer recovery
Young cancer patients who were unable to take a certain drug because of national supply shortages were more likely to relapse than those who received the preferred treatment, according to a report published in the New England Journal of Medicine. Researchers found that 75% of Hodgkin lymphoma patients who received a substitute medication, cyclophosphamide, stayed cancer-free for two years, compared with 88% who received the first-choice medication mechlorethamine. ABC News/The Associated Press
(12/28)
- Lifetime cancer risk poised to rise for both men, women
The lifetime risk of developing cancer is expected to rise to 50% in men and 44% in women by 2027, U.K. researchers said. Despite the predicted increase in cancer cases, they noted that survival rates are going up as well because of better therapies and screening techniques. MedicalDaily.com
(12/20)
| Foundation News
| | |
|
-
Health Care Professional Tools and Training
We've developed materials, partnerships and tools that can help patients prepare for, cope with and manage their cancer journey. Talk with your patients about these resources, and utilize them in your practice to help provide comprehensive support. Check them out.
-
Cancer and Emotional Support
Iram had been married to his high school sweetheart for nine years when he learned he had brain cancer. He thought that by not talking to his wife about his diagnosis, he was protecting her. After she filed for divorce, Iram wondered if his lack of communication pushed someone he loved away. Learn more about Iram’s story and the emotional support services the LIVESTRONG Foundation offers at LIVESTRONG.org/Iram.
| LIVESTRONG SmartQuote
| | |
|
 | It begins to be about how you redefine yourself as a person, drawing on all those things that you have experienced ... making yourself into the new person that you want to be."
--Amy D., cancer survivor
|
| |
| |
|
Read more at
SmartBrief.com |
|
|
|
| |
|
About the LIVESTRONG Foundation
|
The LIVESTRONG Foundation provides free cancer support services to help people cope
with the financial, emotional and practical challenges that accompany the disease.
Created in 1997 by cancer survivor and philanthropist Lance Armstrong, the Foundation
is known for its powerful brand – LIVESTRONG–and for its advocacy on behalf of
survivors and their families. With its iconic yellow LIVESTRONG wristband, the
Foundation has become a symbol of hope and inspiration around the world. Since its
inception, the Foundation has raised nearly $500 million to support cancer survivors
and served 2.5 million people affected by the disease. For more information, visit
LIVESTRONG.org.
|
|
| |
|
Disclaimer
|
The LIVESTRONG Foundation does not necessarily endorse
the opinions that may be mentioned on this site, the
articles are published for informational purposes and
are not intended to be a substitute for professional
medical advice, diagnosis, or treatment. Always seek
the advice of your physician or other qualified health
provider with any questions you may have regarding a
medical condition. Never disregard professional medical
advice or delay in seeking it because of something you
have read on this site.
|
|
| |
| | Recent
LIVESTRONG SmartBrief Issues:
- Thursday, December 20, 2012
- Thursday, December 13, 2012
- Thursday, December 06, 2012
- Thursday, November 29, 2012
- Thursday, November 15, 2012
| | | Lead Editor:
Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®,555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013SmartBrief, Inc.®
Legal Information |
|
